跳至主要内容
临床试验/NCT05736991
NCT05736991招募中不适用

Deep Learning Signature Based on PET-CT Images for Predicting the Novel Grading System of Clinical Stage I Lung Adenocarcinoma

Shanghai Pulmonary Hospital, Shanghai, China4 个研究点 分布在 1 个国家目标入组 600 人开始时间: 2022年11月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
600
试验地点
4
主要终点
Area under the receiver operating characteristic curve

研究概览

简要总结

The purpose of this study is to evaluate the performance of a PET/ CT-based deep learning signature for predicting the grade 3 tumors based on the novel grading system in clinical stage stage I lung adenocarcinoma based on a multicenter prospective cohort.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
20 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • (1) Participants scheduled for surgery for radiological finding of pulmonary lesions from the preoperative thin-section CT scans; (2) The maximum diameter of lesion less than 4 cm on CT scans; (3) The maximum short axis diameter of lymph nodes less than 1 cm on CT scan; (4) The SUVmax of hilar and mediastinal lymph nodes less than 2.5; (5) Pathological confirmation of primary lung adenocarcinoma; (5) Age ranging from 20-75 years; (6) Obtained written informed consent.

排除标准

  • (1) Multiple lung lesions; (2) Poor quality of PET-CT images; (3) Participants with incomplete clinical information; (4) Mucinous adenocarcinomas; (5) Participants who have received neoadjuvant therapy.

结局指标

主要结局

Area under the receiver operating characteristic curve

时间窗: 2022.11-2023.4

Area under the receiver operating characteristic curve

次要结局

  • Sensitivity(2022.11-2023.4)
  • Negative predictive value(2022.11-2023.4)
  • Specificity(2022.11-2023.4)
  • Positive predictive value(2022.11-2023.4)
  • Accuracy(2022.11-2023.4)

研究者

发起方
Shanghai Pulmonary Hospital, Shanghai, China
申办方类型
Other
责任方
Principal Investigator
主要研究者

Chang Chen

Professor

Shanghai Pulmonary Hospital, Shanghai, China

研究点 (4)

Loading locations...

相似试验